Allofill in Carlsbad's Village district operates as the headquarters of Biologica Technologies, a biotech firm developing allograft-derived injectable tissue products on Roosevelt Street. The company's namesake adipose filler retains native extracellular matrix components and growth factors including VEGF and bFGF, producing tissue scaffolds for soft-tissue reconstruction at surgical centers such as Jason Curry, MD Surgical Center. Founded in 2015 as a standalone spinoff of Advanced Biologics — a three-time Orthopedics This Week New Technology Award recipient — the firm launched Allofill at the 2016 American Society of Plastic Surgeons meeting in Los Angeles. The adipose matrix serves as a non-surgical alternative to autologous fat transfer in plastic and reconstructive applications, occupying a product niche alongside the hyaluronic acid fillers administered at practices such as West Dermatology Carlsbad on Palomar Airport Road. The ProteiOS orthobiologic product line delivers the highest documented concentration of non-recombinant BMP-2 among allograft-derived growth factors for spine fusion and bone-grafting procedures.